General
Pfizer fined £84.2m by UK’s competition regulator for overcharging NHS
 

Pfizer fined £84.2m by UK’s competition regulator for overcharging NHS

Shared by:

 
Pfizer and Flynn Pharma were fined by UK’s Competition and Markets Authority for “excessive and unfair prices” for a generic epilepsy drug. The fine issued to Pfizer is one of the largest in the country’s history.
 
today.mims.com
 
12 Dec 2016 - General